CRUISE: Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.

Sponsor
Linkoeping University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05628701
Collaborator
Karolinska University Hospital (Other), Göteborg University (Other), University College London Hospitals (Other)
100
4
5
152.9
25
0.2

Study Details

Study Description

Brief Summary

Background There are no prospective trials comparing the two main reconstructive options after colectomy for Ulcerative colitis, ileal pouch anal anastomosis and ileorectal anastomosis. An attempt on a randomized controlled trial has been made but after receiving standardized information patients insisted on choosing operation themselves.

Methods Adult Ulcerative colitis patients subjected to colectomy eligible for both ileal pouch anastomosis and ileorectal anastomosis are asked to participate and after receiving standardized information the get to choose reconstructive method. Patients not declining reconstruction or not considered eligible for both methods will be followed as controls. The CRUISE study is a prospective, non-randomized, multi-center, controlled trial on satisfaction, QoL, function, and complications between ileal pouch anal anastomosis and ileorectal anastomosis.

Discussion Reconstruction after colectomy is a morbidity-associated as well as a resource-intensive activity with the sole purpose of enhancing function, Quality of Life and patient satisfaction. The aim of this study is to provide the best possible information on the risks and benefits of each reconstructive treatment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ileorectal anastomosis (IRA)
  • Procedure: Ileal pouch anal anastomosis (IPAA)
  • Procedure: ileostomy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The CRUISE study is a prospective, non-randomized, non-blinded, multi-center, controlled trial on satisfaction, QoL, function, and complications between IRA and IPAA and permanent stoma among adult UC patients subjected to subtotal colectomyThe CRUISE study is a prospective, non-randomized, non-blinded, multi-center, controlled trial on satisfaction, QoL, function, and complications between IRA and IPAA and permanent stoma among adult UC patients subjected to subtotal colectomy
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Colectomy Reconstruction for Ulcerative Colitis In Sweden and England: a Multicenter Prospective Comparison Between Ileorectal Anastomosis and Ileal Pouch-Anal Anastomosis After Colectomy in Patients With Ulcerative Colitis.
Actual Study Start Date :
Apr 4, 2017
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2029

Arms and Interventions

Arm Intervention/Treatment
Experimental: IPAA CRUISE

Patients eligible for both operations choosing ileal pouch anal anastomosis.

Procedure: Ileal pouch anal anastomosis (IPAA)
The rectum is removed and a pouch constructed with the distal part opf the ileum which in subsequently anastomosed (connected) to the anus(Ileal pouch anal anastomosis (IPAA)).

Experimental: IRA CRUISE

Patients eligible for both operations choosing ileorectal anastomosis.

Procedure: Ileorectal anastomosis (IRA)
After subtotal colectomy for ulcerative colitis the patients can either keep their end ileostomy or be reconstructed with an anastomosis (connection) between the ileum and the rectal remnant (Ileorectal anastomosis(IRA))

Active Comparator: IRA Control

Patients only eligible for ileorectal anastomosis.

Procedure: Ileorectal anastomosis (IRA)
After subtotal colectomy for ulcerative colitis the patients can either keep their end ileostomy or be reconstructed with an anastomosis (connection) between the ileum and the rectal remnant (Ileorectal anastomosis(IRA))

Active Comparator: IPAA Control

Patients only eligible for ileal pouch anal anastomosis.

Procedure: Ileal pouch anal anastomosis (IPAA)
The rectum is removed and a pouch constructed with the distal part opf the ileum which in subsequently anastomosed (connected) to the anus(Ileal pouch anal anastomosis (IPAA)).

Active Comparator: Ileostomy Control

Patients who decline reconstruction.

Procedure: ileostomy
no reconstruction is performed and the patient is left with his/her ileostomy

Outcome Measures

Primary Outcome Measures

  1. Patient satisfaction [2months]

    yes/no question if the patient is satisfied with his/her choice of operation

  2. Patient satisfaction [1year]

    yes/no question if the patient is satisfied with his/her choice of operation

  3. Patient satisfaction [5 years]

    yes/no question if the patient is satisfied with his/her choice of operation

Secondary Outcome Measures

  1. SF-36(short form-36 item) [2 months]

    The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability

  2. SF-36(short form-36 item) [6 months]

    The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability

  3. SF-36(short form-36 item) [1 year]

    The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability

  4. SF-36(short form-36 item) [2 years]

    The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability

  5. SF-36(short form-36 item) [5 years]

    The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability

  6. Female Sexual Function Index-6 (FSFI-6) [2months]

    6 item questionnaire on female sexual function with total score rangeing from 0-34 with lower scores indicating worse sexual functioning.

  7. Female Sexual Function Index-6 (FSFI-6) [6months]

    6 item questionnaire on female sexual function with total score rangeing from 0-34 with lower scores indicating worse sexual functioning.

  8. Female Sexual Function Index-6 (FSFI-6) [1 year]

    6 item questionnaire on female sexual function with total score rangeing from 0-34 with lower scores indicating worse sexual functioning.

  9. Female Sexual Function Index-6 (FSFI-6) [2 years]

    6 item questionnaire on female sexual function with total score rangeing from 0-34 with lower scores indicating worse sexual functioning.

  10. Female Sexual Function Index-6 (FSFI-6) [5 years]

    6 item questionnaire on female sexual function with total score rangeing from 0-34 with lower scores indicating worse sexual functioning.

  11. International Index of Erectile Function-5 (IIEF-5) [2 months]

    5 item questionnaire on erectile (dys)function rangeing from 5 to 25 with lower scores indicating worse erectile functioning.

  12. International Index of Erectile Function-5 (IIEF-5) [6 months]

    5 item questionnaire on erectile (dys)function rangeing from 5 to 25 with lower scores indicating worse erectile functioning.

  13. International Index of Erectile Function-5 (IIEF-5) [1 year]

    5 item questionnaire on erectile (dys)function rangeing from 5 to 25 with lower scores indicating worse erectile functioning.

  14. International Index of Erectile Function-5 (IIEF-5) [2 years]

    5 item questionnaire on erectile (dys)function rangeing from 5 to 25 with lower scores indicating worse erectile functioning.

  15. International Index of Erectile Function-5 (IIEF-5) [5 years]

    5 item questionnaire on erectile (dys)function rangeing from 5 to 25 with lower scores indicating worse erectile functioning.

  16. Shor health scale (SHS) [2 months]

    IDB specific 4 item qualit of life scale rangeing from 0-24 with higher scores indicating worse quality of life.

  17. Shor health scale (SHS) [6 months]

    IDB specific 4 item qualit of life scale rangeing from 0-24 with higher scores indicating worse quality of life.

  18. Shor health scale (SHS) [1 year]

    IDB specific 4 item qualit of life scale rangeing from 0-24 with higher scores indicating worse quality of life.

  19. Shor health scale (SHS) [2 years]

    IDB specific 4 item qualit of life scale rangeing from 0-24 with higher scores indicating worse quality of life.

  20. Shor health scale (SHS) [5 years]

    IDB specific 4 item qualit of life scale rangeing from 0-24 with higher scores indicating worse quality of life.

  21. Öresland Score [2 months]

    Bowel function score rangeing from 0-17 with higher scores indicating worse functioning.

  22. Öresland Score [6 months]

    Bowel function score rangeing from 0-17 with higher scores indicating worse functioning.

  23. Öresland Score [1 year]

    Bowel function score rangeing from 0-17 with higher scores indicating worse functioning.

  24. Öresland Score [2 years]

    Bowel function score rangeing from 0-17 with higher scores indicating worse functioning.

  25. Öresland Score [5 years]

    Bowel function score rangeing from 0-17 with higher scores indicating worse functioning.

  26. failure [2 months]

    Extirpation of reconstruction or permanant stoma deviation

  27. failure [6 months]

    Extirpation of reconstruction or permanant stoma deviation

  28. failure [1 year]

    Extirpation of reconstruction or permanant stoma deviation

  29. failure [2 years]

    Extirpation of reconstruction or permanant stoma deviation

  30. failure [5 years]

    Extirpation of reconstruction or permanant stoma deviation

  31. reoperations [2 months]

    number of reoperations

  32. reoperations [6 months]

    number of reoperations

  33. reoperations [1 year]

    number of reoperations

  34. reoperations [2 years]

    number of reoperations

  35. reoperations [5 years]

    number of reoperations

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Patients with Ulcerative colitis (UC) aged between 18 and 60

  • Scheduled for or have previously undergone subtotal colectomy and ileostomy.

  • Patients should have sufficient rectal compliance and controllable inflammation in the rectal using topical Mezalasin only.

Exclusion criteria

  • Rectal inflammation of Mayo Score >1

  • Poor sphincter function, perianal disease

  • Uncertainty regarding UC diagnosis P

  • Previous colorectal cancer or severe dysplasia

  • Primary Sclerosing Colitis diagnosis

  • 2 year since subtotal colectomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sahlgrenska Univercity Hospital Gothenburg Sweden SE-413 45
2 Linkoeping University hospital Linköping Sweden 58731
3 Karolinska University Hospital Solna Sweden se-171 76
4 St. Mark's Hospital London United Kingdom HA1 3UJ

Sponsors and Collaborators

  • Linkoeping University
  • Karolinska University Hospital
  • Göteborg University
  • University College London Hospitals

Investigators

  • Study Chair: Caroline Nordenvall, Ass. Prof, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anton Risto, Principal investigator, Linkoeping University
ClinicalTrials.gov Identifier:
NCT05628701
Other Study ID Numbers:
  • 2017/124-31/2
First Posted:
Nov 29, 2022
Last Update Posted:
Nov 29, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Anton Risto, Principal investigator, Linkoeping University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 29, 2022